Johannes Bonatti, MD

Johannes Bonatti, MD
Department: Thoracic and Cardiovascular Surgery
Chair, Heart & Vascular, Abu Dhabi
Location: Abu Dhabi
Mail Code CCAC

UAE, Abu Dhabi,
Type of Doctor:
Adults Only

Biographical Sketch

Johannes Bonatti, MD, FETCS, is Chairman of the Department of Cardiothoracic Surgery, Cleveland Clinic Abu Dhabi and consultant staff in the Department of Cardiothoracic Surgery, Sydell and Arnold Miller Family Heart & Vascular Institute. He is board-certified in cardiothoracic surgery by the European Board of Thoracic and Cardiovascular Surgeons.  His special interests include minimally invasive cardiac surgery, robotic cardiac surgery and vascular biology of coronary artery bypass grafts.

A native of Austria, Dr. Bonatti earned his medical degree from Innsbruck Medical University, Innsbruck, Austria.  After completing multiple medical and surgical internships during three years at the General Public Hospital, Kitzbühel, Austria, he came to the United States for a surgical internship at the Medical College of Virginia, Richmond, Va. He completed his training with a five-year surgical residency at the University Clinic for Surgery in Innsbruck that included specialized training in cardiac and vascular surgery.

Prior to Dr. Bonatti’s appointment to the Cleveland Clinic staff in 2012, he was Professor of Surgery at the University of Maryland Medical Center, Baltimore, Md. He previously was an attending surgeon in the Department of Cardiac Surgery and the Bench to Bedside Manager in the Heart Surgery Research Laboratory at Innsbruck University Hospital. Over the past 10 years he has been a visiting surgeon at leading institutions worldwide, including the University of  Heidelberg, Heidelberg, Germany; the Medical College of Virginia;  General Hospital, Vienna, Austria;  San Camillo Hospital, Alberoni, Italy; Charite University  Clinic, Berlin, Germany; German Heart Center, Munich, Germany; Lenox Hill Hospital, New York, N.Y. and Emory University Hospital, Atlanta, Ga.

Dr. Bonatti has earned an international reputation for innovation in robotic heart surgery and has developed several procedures in the field. He performed the world’s first robotic endoscopic triple and quadruple vessel bypass in the arrested heart and the first simultaneous hybrid coronary intervention using totally endoscopic bypass and drug-eluting stents. He also has organized international workshops on integrated cardiovascular repair and trained teams in robotic surgery in Austria, Czech Republic, Greece, Turkey, India, Australia and the United States.

His pioneering achievements have earned Dr. Bonatti a number of prestigious awards, including Intuitive Surgical’s “Distinguished Robotic Surgeon and Pioneer in da Vinci Cardiac Surgery” award and the “Best Innovator” award from the European-Asian Bridge Society of Cardiothoracic Surgery. He has published more than 190 articles in peer-reviewed journals and serves as a reviewer for many journals, including Journal of Thoracic and Cardiovascular Surgery, Circulation, Cardiology, Heart, Innovations and Journal of Robotic Surgery.

Dr. Bonatti is a member of  the Society of Thoracic Surgeons, the European Association of Cardiothoracic Surgery and the European Society of Cardiology. He is a board member of the International Society of Minimally Invasive Cardiothoracic Surgery, a member of the International Advisory Board of the Japan Robotic Surgery Society and president of the Minimally Invasive Robotic Association.

Education & Fellowships

Fellowship - Innsbruck Medical University
Cardiac Surgery
Innsbruck Austria
Residency - Innsbruck University Hospital
General Surgery
Innsbruck Austria
Residency - Medical College of Virginia Hospital
Richmond, VA USA
Residency - Kitzbuhel General Public Hospital
General Surgery, Anesthesia, Pediatrics, ENT, OB/GYN
Kitzbuhel Austria
Medical School - Innsbruck Medical University
Innsbruck Austria


  • European Board of Thoracic & Cardiovascular Surgeons- Cardiac Surgery

Specialty Interests

Heart surgery, minimally invasive cardiac surgery, robotic cardiac surgery and vascular biology of coronary artery bypass grafts, valve surgery, coronary artery bypass surgery

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/8/2015, Dr. Bonatti has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

Languages Spoken

  • English